Postdoctoral scientist Sarah Neuman and Professor Arash Bashirullah find bridge-shaped proteins that channel the flow of essential lipids inside cells.
Pharmaceutical Sciences
Leadership, Learning, and Drug Development
Alum Elham Nejati (PhD ’12) advances new therapeutics through formulation and process development at Gilead Sciences.
New Injectable Gel Treatment Offers Promise for Tough-to-Treat Brain Tumors
School of Pharmacy Assistant Professor Quanyin Hu and collaborators publish preclinical results on a new approach to prevent glioblastoma recurrence.
2022 Five of the Future
Meet recent UW–Madison School of Pharmacy alumni who are leading their fields forward.
Two School of Pharmacy Faculty Honored with Coveted Vilas Professorships and Awards
Professor Weiping Tang and Associate Professor Warren Rose receive recognition from UW–Madison for their distinguished research.
New Lachman Institute at the School of Pharmacy Advances Pharmaceutical Development
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move therapies from the lab into the clinic.
Biodegradable Gel Boosts Immune System’s Attack on Several Cancers in Mice
School of Pharmacy Assistant Professor Quanyin Hu and his CIPT Lab team, along with research collaborators, develop a gel that effectively keeps in check certain tumors, with their findings published in Nature Communications By Eric Hamilton …
Using Clinical Chemistry to Help Others
Alumna Gabrielle Winston-McPherson conducts novel research and meets patient needs in the core automation lab at Henry Ford Health System.
School of Pharmacy Professor and Alum Receive Top Honor for Medical and Biological Engineers
Professor Seungpyo Hong and alumna Heidi Mansour are selected for their contributions to nanotechnology and pulmonary disease treatment.
$1M Grant Propels Inhalable Nanomedicine Research
With new funding from the Falk Medical Trust, Professor Seungpyo Hong and Allan Brasier, executive director of the UW Institute for Clinical and Translational Research, are paving the way for a novel treatment for idiopathic pulmonary fibrosis.